Laquinimod, a new oral drug for multiple sclerosis

Lancet. 2008 Jun 21;371(9630):2059-60. doi: 10.1016/S0140-6736(08)60894-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Oral
  • Humans
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology
  • Quinolones / administration & dosage
  • Quinolones / adverse effects
  • Quinolones / therapeutic use*

Substances

  • Quinolones
  • laquinimod